BioStable Science & Engineering
Austin, US · Delaware corporation · 3 known investors
Find your way into BioStable Science & Engineering
Sign up to see every warm intro you have to BioStable Science & Engineering
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioStable Science & Engineering team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
Founders & leadership
JW
John WheelerNamed on SEC filing
JC
Joe CunninghamNamed on SEC filing
DA
David AdairNamed on SEC filing
DS
David StrongNamed on SEC filing
Investors · 3
Louisiana Fundslisted by Louisiana FundsBaton Rouge
How we know: Louisiana Funds's portfolio page · Not right? Tell us
Rex Health Ventureslisted by Rex Health VenturesRaleigh · $250K – $500K
How we know: Rex Health Ventures's portfolio page · funding news · Not right? Tell us
Orlando Health Venturesreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2020
▶$4.2MraisedMar 2020 · 9 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMar 2020 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John WheelerExecutive Officer, Director
- Joe CunninghamDirector
- David AdairDirector
- David StrongDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does BioStable Science & Engineering do?
- Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
- Who are BioStable Science & Engineering's investors?
- BioStable Science & Engineering's investors include Louisiana Funds, Rex Health Ventures, Orlando Health Ventures.
- How much funding has BioStable Science & Engineering raised?
- BioStable Science & Engineering has disclosed $4.2M raised across 1 round.
- Where is BioStable Science & Engineering headquartered?
- BioStable Science & Engineering is headquartered in Austin, US.